Recurrences were more likely in PCMZL, and mutations in TNFAIP3 and FAS were not identified in primary cutaneous CD4‐positive small/medium lymphoproliferative disorder [77]. The gene discussed is CD4; the disease is primary cutaneous marginal zone B-cell lymphoma.